Jeffrey Hawkins is the President and Chief Executive Officer at Quantum-Si Incorporated (QUANTUM SI INC CLASS A), a company focused on revolutionizing proteomics through innovative semiconductor chip technology. With a robust background in the life sciences and technology sectors, Hawkins has been instrumental in steering Quantum-Si towards its mission of enabling groundbreaking protein research. Before joining Quantum-Si, Hawkins held various leadership positions in the industry, including roles at Illumina, where he played a key part in developing and commercializing next-generation sequencing technologies. At Quantum-Si, Hawkins leads the company's efforts to develop and commercialize its proprietary Platinum™ protein sequencing platform. His strategic vision and deep understanding of the market have been pivotal in driving the company's growth and establishing its position as a leader in the proteomics field. Under his leadership, Quantum-Si has made significant strides in advancing the technology that promises to transform the way scientists study proteins, opening new avenues for drug discovery and personalized medicine. Hawkins' achievements extend beyond his current role at Quantum-Si. He has a proven track record of successfully bringing innovative products to market, having contributed to the development of several groundbreaking technologies throughout his career. His expertise in scaling businesses and fostering innovation has been recognized by industry peers and has earned him a reputation as a thought leader in the life sciences sector. As the CEO of Quantum-Si, Hawkins continues to inspire his team and the broader scientific community with his commitment to advancing the frontiers of proteomics.